Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Open Label Trial of 6 Months vs. 12 Months Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation In ST-elevation Myocardial Infarction

NCT01459627 is registered in ClinicalTrials.gov with Maasstad Hospital as lead sponsor.

NCT NCT01459627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01459627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Open Label Trial of 6 Months vs. 12 Months Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation In ST-elevation Myocardial Infarction
Lead sponsor
Maasstad Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
August 31, 2017
Enrollment
1,100 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, myocardial infarction